Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Investigative Ophthalmology & Visual Science|October 3, 2001
Downregulation of differentiation specific gene expression by oxidative stress in ARPE-19 cellsM Alizadeh, M Wada, C M Gelfman, et al.
Veterinary Pathology|March 6, 2009
Comparative pathology of murine mucolipidosis types II and IIICP Vogel, B J Payne, R Read, et al.
Current Eye Research|January 23, 2002
Density-dependent expression of FGF-2 in response to oxidative stress in RPE cells in vitroM Wada, C M Gelfman, H Matsunaga, et al.
Molecular Therapy. Methods & Clinical Development|July 17, 2020
Analysis of Aflibercept Expression in NHPs following Intravitreal Administration of ADVM-022, a Potential Gene Therapy for nAMDSzilárd Kiss, Ruslan Grishanin, Aivan Nguyen, et al.
Investigative Ophthalmology & Visual Science|October 27, 2007
Mice lacking alpha/beta subunits of GlcNAc-1-phosphotransferase exhibit growth retardation, retinal degeneration, and secretory cell lesionsClaire M Gelfman, Peter Vogel, Tawfik M Issa, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|April 9, 2021
Comprehensive Preclinical Assessment of ADVM-022, an Intravitreal Anti-VEGF Gene Therapy for the Treatment of Neovascular AMD and Diabetic Macular EdemaClaire M Gelfman, Ruslan Grishanin, Kristina Oresic Bender, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 18, 2023
Preclinical evaluation of ADVM-062, a novel intravitreal gene therapy vector for the treatment of blue cone monochromacyKelly Hanna, Julio Nieves, Christine Dowd, et al.
Translational Vision Science & Technology|February 3, 2021
Long-Term Safety Evaluation of Continuous Intraocular Delivery of Aflibercept by the Intravitreal Gene Therapy Candidate ADVM-022 in Nonhuman PrimatesSzilárd Kiss, Kristina Oresic Bender, Ruslan N Grishanin, et al.
Pageof 4